UPDATE : Saturday, October 12, 2019
상단여백
Genexine sets up joint firm in Thailand by Lee Han-soo 2019-09-26 17:00
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question by Lee Han-soo 2019-09-26 15:39
‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’ by Jeong Sae-im 2019-09-26 15:24
Celltrion to start marketing Herzuma in Middle East by Lee Han-soo 2019-09-26 15:02
Researchers discover spreading probability of wet macular degeneration by Lee Han-soo 2019-09-26 14:23
라인
Ranitidine heartburn drugs banned due to carcinogen risk by Lee Hye-seon 2019-09-26 13:32
Pfizer’s leukemia therapy Besponsa to get insurance benefit by Kim Yun-mi 2019-09-26 11:26
'Xtandi emerges as convenient treatment option for prostate cancer patients' by Lee Han-soo 2019-09-25 17:39
Korea, Uzbekistan speed up public health cooperation by Kwak Sung-sun 2019-09-25 15:26
Ministry to announce results of ranitidine testing for carcinogen by Lee Hye-seon 2019-09-25 14:46
라인
Helixmith blames hospital for absurd drug mix-up by Jeong Sae-im 2019-09-25 13:42
NCC develops new chemotherapy to increase survival of osteosarcoma patients by Lee Han-soo 2019-09-25 11:48
Court rejects Kolon’s appeal over Invossa license revocation by Jeong Sae-im 2019-09-25 11:18
Huons, Lipac Oncology to co-develop bladder cancer treatment by Lee Han-soo 2019-09-25 11:18
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor by Lee Han-soo 2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment by Lee Han-soo 2019-09-24 17:00
Hanmi’s US partner to unveil results of anticancer drug study by Lee Han-soo 2019-09-24 17:00
Thyroidectomy ups depression risk by 1.81 folds within 2 months by Kim Eun-young 2019-09-24 17:00
Why using end-to-end services should be part of a drug product strategy by Lee Han-soo 2019-09-24 16:54
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment by Lee Han-soo 2019-09-24 16:38
여백
여백
여백
Back to Top